Income statement
USD
Annual
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 3M | 1M | 250K | 0 | 0 |
| Gross Profit | 2M | 1M | 250K | -27K | -447 |
| Operating Income | 996K | 30K | -447K | -1M | -691K |
| EBITDA | -772K | 497K | -2M | -2M | -691K |
| Net Income | -1M | -509K | -4M | -3M | -691K |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 251 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sunset Island Group, Inc. (SIGO) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +98.7%, EPS growth of -173.7%, a dividend yield of 0.0%. What stands out right now is revenue +98.7%, EPS -173.7%, free cash flow +3572.5% with operating margin 34.3% and ROIC -16.5%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SIGO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SIGO
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SIGO Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SIGO and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$690.7K
+79.2% YoY
Free Cash Flow
-$678.9K
+53.4% YoY
Revenue Growth
+98.7%
EPS Growth
-173.7%
Gross Margin
79.7%
Net Margin
-49.5%
Income statement
USD
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 3M | 1M | 250K | 0 | 0 |
| Gross Profit | 2M | 1M | 250K | -27K | -447 |
| Operating Income | 996K | 30K | -447K | -1M | -691K |
| EBITDA | -772K | 497K | -2M | -2M | -691K |
| Net Income | -1M | -509K | -4M | -3M | -691K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1M | 363K | 263K | 116K | 25K |
| Total Assets | 1M | 557K | 566K | 305K | 39K |
| Total Liabilities | 11M | 8M | 8M | 4M | 405K |
| Shareholder Equity | -9M | -8M | -7M | -4M | -366K |
| Total Debt | 3M | 3M | 3M | 2M | 333K |
| Net Debt | 2M | 3M | 2M | 1M | 308K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
679K
+53.4% YoY
Capital Expenditures
0
Free Cash Flow
679K
+53.4% YoY
Key ratios
Gross Margin
79.7%
Operating Margin
34.3%
Net Margin
-49.5%
ROE
17.3%
Debt / Equity
-0.33x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.